skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,232  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: Database: ProQuest Central remove language: Russian remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The Growth Response to Growth Hormone (GH) Treatment in Children with Isolated GH Deficiency Is Independent of the Presence of the Exon 3-Minus Isoform of the GH Receptor
The Growth Response to Growth Hormone (GH) Treatment in Children with Isolated GH Deficiency Is Independent of the Presence of the Exon 3-Minus Isoform of the GH Receptor
Material Type:
Article 		Add to My Research

The Growth Response to Growth Hormone (GH) Treatment in Children with Isolated GH Deficiency Is Independent of the Presence of the Exon 3-Minus Isoform of the GH Receptor

The journal of clinical endocrinology and metabolism, 2006-10, Vol.91 (10), p.4171-4174 [Peer Reviewed Journal]

2006 INIST-CNRS ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2006-0063 ;PMID: 16868057 ;CODEN: JCEMAZ

Full text available

Citations Cited by
2
Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial
Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial
Material Type:
Article 		Add to My Research

Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial

The Lancet infectious diseases, 2013-11, Vol.13 (11), p.927-935 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 2013 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(13)70257-3 ;PMID: 24074642 ;CODEN: LANCAO

Full text available

Citations Cited by
3
Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology
Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology
Material Type:
Article 		Add to My Research

Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology

Journal of clinical pathology, 2006-05, Vol.59 (5), p.513-517 [Peer Reviewed Journal]

Copyright 2006 Journal of Clinical Pathology ;2006 INIST-CNRS ;Copyright: 2006 Copyright 2006 Journal of Clinical Pathology ;Copyright © 2006 The BMJ Publishing Group and the Association of Clinical Pathologists ;ISSN: 0021-9746 ;EISSN: 1472-4146 ;DOI: 10.1136/jcp.2004.024570 ;PMID: 16484445 ;CODEN: JCPAAK

Full text available

Citations Cited by
4
Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial
Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial
Material Type:
Article 		Add to My Research

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

The Lancet infectious diseases, 2012-02, Vol.12 (2), p.111-118 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 2012 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(11)70290-0 ;PMID: 22018760 ;CODEN: LANCAO

Full text available

Citations Cited by
5
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
Material Type:
Article 		Add to My Research

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial

Annals of the rheumatic diseases, 2013-02, Vol.72 (2), p.179-186 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2014 INIST-CNRS ;Copyright: 2013 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2013 ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2012-202231 ;PMID: 23117245 ;CODEN: ARDIAO

Full text available

Citations Cited by
6
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Material Type:
Article 		Add to My Research

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2013-03, Vol.381 (9869), p.817-824 [Peer Reviewed Journal]

Elsevier Ltd ;2014 INIST-CNRS ;Copyright Elsevier Limited Mar 9, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61767-X ;PMID: 23312829 ;CODEN: LANCAO

Full text available

Citations Cited by
7
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Material Type:
Article 		Add to My Research

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

The Lancet (British edition), 2014-01, Vol.383 (9911), p.31-39 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 4, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)61719-5 ;PMID: 24094768 ;CODEN: LANCAO

Full text available

Citations Cited by
8
Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection
Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection
Material Type:
Article 		Add to My Research

Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection

The Journal of clinical investigation, 2022-01, Vol.132 (1), p.1-11 [Peer Reviewed Journal]

COPYRIGHT 2022 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Jan 2022 ;2022 Mitchell et al. 2022 Mitchell et al. ;ISSN: 1558-8238 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI150937 ;PMID: 34762600

Full text available

Citations Cited by
9
Bronchial Secretory Immunoglobulin A Deficiency Correlates With Airway Inflammation and Progression of Chronic Obstructive Pulmonary Disease
Bronchial Secretory Immunoglobulin A Deficiency Correlates With Airway Inflammation and Progression of Chronic Obstructive Pulmonary Disease
Material Type:
Article 		Add to My Research

Bronchial Secretory Immunoglobulin A Deficiency Correlates With Airway Inflammation and Progression of Chronic Obstructive Pulmonary Disease

American journal of respiratory and critical care medicine, 2011-08, Vol.184 (3), p.317-327 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright American Thoracic Society Aug 1, 2011 ;Copyright © 2011 American Thoracic Society 2011 ;ISSN: 1073-449X ;EISSN: 1535-4970 ;DOI: 10.1164/rccm.201010-1629OC ;PMID: 21512171

Full text available

Citations Cited by
10
Autonomic Denervation Added to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: A Randomized Clinical Trial
Autonomic Denervation Added to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: A Randomized Clinical Trial
Material Type:
Article 		Add to My Research

Autonomic Denervation Added to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation: A Randomized Clinical Trial

Journal of the American College of Cardiology, 2013-12, Vol.62 (24), p.2318-2325 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2013.06.053 ;PMID: 23973694 ;CODEN: JACCDI

Full text available

Citations Cited by
11
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Material Type:
Article 		Add to My Research

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2014-08, Vol.384 (9941), p.403-413 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 2, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)60494-3 ;PMID: 24907225 ;CODEN: LANCAO

Full text available

Citations Cited by
12
Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease: A Mendelian Randomization Analysis
Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease: A Mendelian Randomization Analysis
Material Type:
Article 		Add to My Research

Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease: A Mendelian Randomization Analysis

Journal of the American College of Cardiology, 2012-12, Vol.60 (25), p.2631-2639 [Peer Reviewed Journal]

2014 INIST-CNRS ;Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2012.09.017 ;PMID: 23083789 ;CODEN: JACCDI

Full text available

Citations Cited by
13
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Material Type:
Article 		Add to My Research

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

The Lancet (British edition), 2013-01, Vol.381 (9861), p.125-132 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 12, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61134-9 ;PMID: 23158522 ;CODEN: LANCAO

Full text available

Citations Cited by
14
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Material Type:
Article 		Add to My Research

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

The Lancet (British edition), 2011, Vol.377 (9767), p.721-731 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 26-Mar 4, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)61354-2 ;PMID: 21296403 ;CODEN: LANCAO

Full text available

Citations Cited by
15
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Material Type:
Article 		Add to My Research

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

The Lancet (British edition), 2011-03, Vol.377 (9769), p.914-923 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 12-Mar 18, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60070-6 ;PMID: 21376385 ;CODEN: LANCAO

Full text available

Citations Cited by
16
Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study
Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study
Material Type:
Article 		Add to My Research

Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study

The Lancet (British edition), 2011-06, Vol.377 (9781), p.1938-1947 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 4-Jun 10, 2011 ;2011 Elsevier Ltd. All rights reserved. 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60547-3 ;PMID: 21601270 ;CODEN: LANCAO

Full text available

Citations Cited by
17
Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial
Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial
Material Type:
Article 		Add to My Research

Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial

Vaccine, 2008-05, Vol.26 (19), p.2378-2388 [Peer Reviewed Journal]

Elsevier Ltd ;2008 Elsevier Ltd ;2008 INIST-CNRS ;Copyright Elsevier Limited May 2, 2008 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2008.02.068 ;PMID: 18407382 ;CODEN: VACCDE

Full text available

Citations Cited by
18
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Material Type:
Article 		Add to My Research

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

Annals of the rheumatic diseases, 2010-10, Vol.69 (10), p.1809-1815 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 INIST-CNRS ;Copyright: 2010 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2009.114264 ;PMID: 20551155 ;CODEN: ARDIAO

Full text available

Citations Cited by
19
Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials
Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials
Material Type:
Article 		Add to My Research

Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials

The Lancet (British edition), 2011-08, Vol.378 (9791), p.584-594 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 13-Aug 19, 2011 ;2011 Elsevier Ltd. All rights reserved. 2011 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60872-6 ;PMID: 21803414 ;CODEN: LANCAO

Full text available

Citations Cited by
20
Unintentional movements produced by back-coupling between the actual and referent body configurations: violations of equifinality in multi-joint positional tasks
Unintentional movements produced by back-coupling between the actual and referent body configurations: violations of equifinality in multi-joint positional tasks
Material Type:
Article 		Add to My Research

Unintentional movements produced by back-coupling between the actual and referent body configurations: violations of equifinality in multi-joint positional tasks

Experimental brain research, 2014-12, Vol.232 (12), p.3847-3859 [Peer Reviewed Journal]

Springer-Verlag Berlin Heidelberg 2014 ;2015 INIST-CNRS ;COPYRIGHT 2014 Springer ;ISSN: 0014-4819 ;EISSN: 1432-1106 ;DOI: 10.1007/s00221-014-4059-x ;PMID: 25150552 ;CODEN: EXBRAP

Full text available

Citations Cited by

Results 1 - 20 of 1,232  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (1,154)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1984  (14)
  2. 1984 To 1995  (26)
  3. 1996 To 2004  (169)
  4. 2005 To 2014  (713)
  5. After 2014  (311)
  6. More options open sub menu

Resource Type 

  1. Articles  (1,224)
  2. Reviews  (7)
  3. Conference Proceedings  (1)
  4. More options open sub menu

Language 

  1. English  (1,021)
  2. Japanese  (82)
  3. Ukrainian  (22)
  4. German  (20)
  5. Lithuanian  (6)
  6. French  (4)
  7. Polish  (2)
  8. Latvian  (2)
  9. Serbian  (1)
  10. Portuguese  (1)
  11. Spanish  (1)
  12. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait